> **Technical note:** A tool-side retrieval outage occurred in this session. The available research tools returned no citable evidence contexts, so **PMIDs, publication URLs, publication dates, abstract quotes, and evidence-backed statistics could not be retrieved**. As a result, a fully cited research report on **PAX3 Waardenburg Spectrum** cannot be produced in this run.
>
> **What is available instead:** an **unsourced scaffold** for the disease entry. In compact form, that scaffold treats the target concept as **PAX3-associated Waardenburg phenotypes**, likely centered on **Waardenburg syndrome type 1 (WS1)** and **type 3 / Klein-Waardenburg syndrome (WS3)**, with draft placeholders for: disease identifiers; synonyms; core phenotypes (hearing loss, pigmentary abnormalities, dystopia canthorum/telecanthus, limb anomalies in WS3); causal gene (**PAX3**); inheritance (provisionally autosomal dominant); developmental / neural-crest–melanocyte pathophysiology; affected anatomy (inner ear, iris, skin, hair, craniofacial structures, upper limb); diagnostics; prognosis; supportive management; prevention/counseling; and model organisms.
>
> **Compact rerun plan when retrieval is restored:**
> 1. Query **GeneReviews** for the clinical overview, diagnosis, inheritance, management, and differential diagnosis: `Waardenburg syndrome PAX3 GeneReviews`.
> 2. Query **OMIM** for phenotype and gene entries: `PAX3 Waardenburg syndrome type 1 OMIM` and `PAX3 Waardenburg syndrome type 3 OMIM`.
> 3. Query **Orphanet** for classification and epidemiology: `Orphanet Waardenburg syndrome type 1 PAX3`.
> 4. Query **ClinVar / ClinGen / gnomAD** for variant interpretation and allele frequency: `PAX3 Waardenburg syndrome ClinVar`, `ClinGen PAX3 Waardenburg`, `gnomAD PAX3`.
> 5. Query **PubMed** with 2023-2024 priority for recent reviews and case series: `PAX3 Waardenburg syndrome 2023`, `PAX3 Waardenburg syndrome 2024`, `Waardenburg syndrome type 1 PAX3 review`, `Klein-Waardenburg PAX3`.
> 6. Query **HPO** for standardized phenotype terms, **DECIPHER** for structural variation, and **MGI / ZFIN** for model-organism evidence.
> 7. Rebuild the report only after those sources are available, adding verified identifiers, phenotype frequencies, variant-level evidence, recent statistics, mechanistic citations, and exact PMIDs/URLs/dates.
>
> **Use restriction:** Treat the current output only as a drafting scaffold. It should be rerun and replaced with a fully cited version once literature retrieval is functioning again.


*Blockquote: This blockquote explains why a fully cited report could not be produced in this session and provides a compact unsourced scaffold summary plus a practical step-by-step retrieval plan for rerun.*